Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): protocol for a randomised controlled trial.
Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): protocol for a randomised controlled trial.
复制标题
DOI:
10.1186/s13063-018-2500-3
复制
发表时间:
2018-02-22
期刊:
影响因子:
2.5
通讯作者:
Crawley E
中科院分区:
文献类型:
--
作者:
Baos S;Brigden A;Anderson E;Hollingworth W;Price S;Mills N;Beasant L;Gaunt D;Garfield K;Metcalfe C;Parslow R;Downing H;Kessler D;Macleod J;Stallard P;Knoop H;Van de Putte E;Nijhof S;Bleijenberg G;Crawley E
Paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is a relatively common and disabling condition. The National Institute for Health and Clinical Excellence (NICE) recommends Cognitive Behavioural Therapy (CBT) as a treatment option for paediatric CFS/ME because there is good evidence that it is effective. Despite this, most young people in the UK are unable to access local specialist CBT for CFS/ME. A randomised controlled trial (RCT) showed FITNET was effective in the Netherlands but we do not know if it is effective in the National Health Service (NHS) or if it is cost-effective. This trial will investigate whether FITNET-NHS is clinically effective and cost-effective in the NHS. Seven hundred and thirty-four paediatric patients (aged 11–17 years) with CFS/ ME will be randomised (1:1) to receive either FITNET-NHS (online CBT) or Activity Management (delivered via video call). The internal pilot study will use integrated qualitative methods to examine the feasibility of recruitment and the acceptability of treatment. The full trial will assess whether FITNET-NHS is clinically effective and cost-effective. The primary outcome is disability at 6 months, measured using the SF-36-PFS (Physical Function Scale) questionnaire. Cost-effectiveness is measured via cost-utility analysis from an NHS perspective. Secondary subgroup analysis will investigate the effectiveness of FITNET-NHS in those with co-morbid mood disorders. If FITNET-NHS is found to be feasible and acceptable (internal pilot) and effective and cost-effective (full trial), its provision by the NHS has the potential to deliver substantial health gains for the large number of young people suffering from CFS/ME but unable to access treatment because there is no local specialist service. This trial will provide further evidence evaluating the delivery of online CBT to young people with chronic conditions. ISRCTN registry, registration number: ISRCTN18020851. Registered on 4 August 2016. The online version of this article (10.1186/s13063-018-2500-3) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
6.6
作者:
Kempke, Stefan;Goossens, Lutgarde;Van Wambeke, Peter
通讯作者:
Van Wambeke, Peter
影响因子:
6.9
作者:
Chalder, T.;Deary, V.;Walwyn, R.
通讯作者:
Walwyn, R.
影响因子:
2.9
作者:
Crawley EM;Emond AM;Sterne JA
通讯作者:
Sterne JA
影响因子:
2.5
作者:
Crawley E;Mills N;Hollingworth W;Deans Z;Sterne JA;Donovan JL;Beasant L;Montgomery A
通讯作者:
Montgomery A
影响因子:
2.5
作者:
Crawley, Esther;Mills, Nicola;Montgomery, Alan
通讯作者:
Montgomery, Alan